482
Views
9
CrossRef citations to date
0
Altmetric
Perspective

The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?

, , &
Pages 475-486 | Received 25 Feb 2018, Accepted 04 Jul 2018, Published online: 18 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bin Wu, Zhenhua Wang & Qing Xie. (2019) Cost-effectiveness of novel regimens for Chinese patients with chronic hepatitis C. Current Medical Research and Opinion 35:5, pages 847-857.
Read now

Articles from other publishers (8)

Laura A. Barufaldi, Rita de C.R. de Albuquerque, Aline do Nascimento, Luís Felipe L. Martins, Ivan R. Zimmermann & Mirian C. de Souza. (2023) Cost-Effectiveness Analysis of Monoclonal Antibodies Associated With Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer. Value in Health Regional Issues 37, pages 33-40.
Crossref
Wolfgang Greiner & Julian Witte. (2022) Grundkonzepte und Einsatz von Kosten-Nutzen-Bewertungen im internationalen Überblick. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 174, pages 111-118.
Crossref
Vladica M. Veličković, Pablo Arija Prieto, Milica Krga & Ana Maria Jorge. (2022) Superabsorbent wound dressings versus foams dressings for the management of moderate-to-highly exuding venous leg ulcers in French settings: An early stage model-based economic evaluation. Journal of Tissue Viability 31:3, pages 523-530.
Crossref
Vladica M. Veličković, Mate Szilcz, Zoran Milošević, Thomas Godfrey & Uwe Siebert. (2021) Cost‐effectiveness analysis of superabsorbent wound dressings in patients with moderate‐to‐highly exuding leg ulcers in Germany. International Wound Journal 19:2, pages 447-459.
Crossref
Frank Sandmann, Mary Ramsay, W. John Edmunds, Yoon H. Choi & Mark Jit. (2021) How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations. Value in Health 24:10, pages 1391-1399.
Crossref
Afschin Gandjour. (2020) A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency. BMC Health Services Research 20:1.
Crossref
Georg Kemmler, Eva Gamper, Virginie Nerich, Richard Norman, Rosalie Viney, Bernhard Holzner & Madeleine King. (2019) German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30. Quality of Life Research 28:12, pages 3197-3211.
Crossref
Simon van der Pol, Lisa A. de Jong, Pepijn Vemer, Danielle E.M.C. Jansen & Maarten J. Postma. (2019) Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier. Value in Health 22:10, pages 1119-1127.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.